Literature DB >> 3881099

Reductases for carbonyl compounds in human liver.

T Nakayama, A Hara, K Yashiro, H Sawada.   

Abstract

Two aldehyde reductases with mol. wt 78,000 and 32,000 and one carbonyl reductase with mol. wt 31,000 were purified to homogeneity from human liver cytosol. The high molecular weight aldehyde reductase exhibited properties similar to alcohol dehydrogenase; it had a single subunit of mol. wt 41,000 and a pI value of 10 to 10.5, and showed preference for NADH over NADPH as cofactor and sensitivity to SH-reagents, pyrazole, o-phenanthroline and isobutyramide. The enzyme reduced aliphatic and aromatic aldehydes, alicyclic ketones and alpha-diketones and an optimal pH of 6.0, and oxidized various alcohols with NAD as a cofactor at an optimal pH of 8.8. The identity of the enzyme with alcohol dehydrogenase was established by starch gel electrophoresis and co-purification of the two enzymes. The other enzymes were NADPH-dependent and monomeric reductases; the aldehyde reductase reduced aldehydes, hexonates and alpha-diketones and was sensitive to barbiturates, diphenylhydantoin and valproate, while the carbonyl reductase showed a broad substrate specificity for aldehydes, ketones and quinones and was inhibited by SH-reagent, quercitrin and benzoic acid. The latter enzyme appeared in three multiforms with different charges which occurred in differing ratios in liver specimens. Comparison of kinetic constants for aldehydes among the enzymes indicated that alcohol dehydrogenase is the best reductase with the highest affinity and Kcat values. The enzyme also catalyzed oxidation and reduction of aromatic aldehydes in the presence of NAD at physiological pH of 7.2. Tissue distribution of the three enzymes and variation of their specific activities in human livers were examined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881099     DOI: 10.1016/0006-2952(85)90108-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes.

Authors:  Kaori Matsumoto; Tetsuya Hasegawa; Junichi Koyanagi; Tamiko Takahashi; Masayuki Akimoto; Kenji Sugibayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-06       Impact factor: 2.441

2.  Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3 alpha-hydroxysteroid dehydrogenase activity.

Authors:  Y Deyashiki; H Taniguchi; T Amano; T Nakayama; A Hara; H Sawada
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

3.  Kinetic mechanism of pulmonary carbonyl reductase.

Authors:  K Matsuura; T Nakayama; M Nakagawa; A Hara; H Sawada
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Enzymatic formation of prostaglandin F2 alpha in human brain.

Authors:  H Hayashi; Y Fujii; K Watanabe; O Hayaishi
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

5.  Aldehyde reductase is a major protein associated with 3-deoxyglucosone reductase activity in rat, pig and human livers.

Authors:  T Kanazu; M Shinoda; T Nakayama; Y Deyashiki; A Hara; H Sawada
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.